29.10.2012 • News • Nomad Bioscience • Bayer • Agrochemistry

Nomad Bioscience, Bayer Cropscience to Enter into Strategic Partnership

Nomad Bioscience, a plant biotechnology company, has announced that the company has entered into a strategic joint research and development agreement with Bayer CropScience, Monheim, Germany.

The multi-year collaboration continues an earlier research program and provides Bayer CropScience broad exclusivity with regard to crop species and plant traits. The financial and other material provisions of the agreement were not disclosed.

Dr. Yuri Gleba, Nomad's CEO said: "Since the advent of genetically engineered plants that have been first produced in 1982 and commercialized in 1994, this is the only new technology with huge business potential, one that allows to extract value in agriculture in an entirely different way. To bring it to the market is a massive undertaking, and we are extremely happy to have one of the largest agribusiness companies as our strategic partner.

Virtual Event

CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.